PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 36.90
+1.93 (5.52%)
Mar 27, 2026, 4:00 PM EDT
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 5.08 billion as of March 30, 2026. Its market cap has increased by 8.02% in one year.
Market Cap
5.08B
Enterprise Value
4.95B
Revenue
667.47M
Ranking
n/a
PE Ratio
144.26
Stock Price
36.90
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 5.08B, an increase of 28.87%. That is a compound annual growth rate of 7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 5.08B | 23.54% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai OPM Biosciences | 5.59B |
| Novogene | 5.59B |
| Beijing Konruns Pharmaceutical | 5.57B |
| Kexing Biopharm | 5.38B |
| ChemPartner PharmaTech | 5.11B |
| Innovita Biological Technology | 4.86B |
| Beijing Bohui Innovation Biotechnology Group | 4.84B |
| Wuhan Hvsen Biotechnology | 4.80B |